New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
12:00 EDTRLYPRelypsa falls 13.4%
Relypsa is down 13.4%, or $5.47, to $35.42
News For RLYP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 20, 2015
07:26 EDTRLYPBMO Capital specialty pharma analyst holds analyst/industry conference call
Specialty Pharmaceuticals Analyst Maris, along with Dr. Kosiborod, Cardiologist, St. Luke's Mid-America Heart Institute discuss limitations of current standard of care and innovative new treatments for Hyperkalemia, including ZS Pharma’s ZS-9 and Relypsa’s Patiromer on an Analyst/Industry conference call to be held on April 27 at 11 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use